Your browser doesn't support javascript.
loading
Insights from CTTACC: immune system reset by cellular therapies for chronic illness after trauma, infection, and burn.
Bertram, Kenneth; Cox, Charles; Alam, Hasan; Lowell, Clifford; Cuschieri, Joseph; Parekkadan, Biju; Pati, Shibani.
Afiliação
  • Bertram K; Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA. Electronic address: kabertra@wakehealth.edu.
  • Cox C; Department of Pediatric Surgery, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Alam H; Department of Surgery, Northwestern University, Chicago, Illinois, USA.
  • Lowell C; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
  • Cuschieri J; Department of Surgery, University of California San Francisco, San Francisco, California, USA.
  • Parekkadan B; Department of Biomedical Engineering, Rutgers University, Piscataway, New Jersey, USA.
  • Pati S; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA; Department of Surgery, University of California San Francisco, San Francisco, California, USA.
Cytotherapy ; 26(7): 714-718, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38506768
ABSTRACT
BACKGROUND

AIMS:

In this paper, we present a review of several selected talks presented at the CTTACC conference (Cellular Therapies in Trauma and Critical Care) held in Scottsdale, AZ in May 2023. This conference review highlights the potential for cellular therapies to "reset" the dysregulated immune response and restore physiologic functions to normal. Improvements in medical care systems and technology have increasingly saved lives after major traumatic events. However, many of these patients have complicated post-traumatic sequelae, ranging from short-term multi-organ failure to chronic critical illness. METHODS/

RESULTS:

Patients with chronic critical illness have been found to have dysregulated immune responses. These abnormal and harmful immune responses persist for years after the initial insult and can potentially be mitigated by treatment with cellular therapies.

CONCLUSIONS:

The sessions emphasized the need for more research and clinical trials with cellular therapies for the treatment of a multitude of chronic illnesses post-trauma, radiation injury, COVID-19, burns, traumatic brain injury (TBI) and other chronic infections.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Queimaduras / Terapia Baseada em Transplante de Células e Tecidos / COVID-19 Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Queimaduras / Terapia Baseada em Transplante de Células e Tecidos / COVID-19 Idioma: En Ano de publicação: 2024 Tipo de documento: Article